STOCK TITAN

Aveanna Healthcare Announces Successful Debt Refinancing

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Aveanna Healthcare (Nasdaq: AVAH) has successfully completed a significant debt refinancing transaction. The company has refinanced its $886.0 million first lien term loans and secured $439.0 million in incremental first lien term loans, bringing the total to $1.325 billion with extended maturity to 2032.

Additionally, AVAH increased its revolving credit facility from $170.3 million to $250.0 million, extending its maturity to 2030. The company used the proceeds to fully repay its $415.0 million second lien term loans. Barclays Bank PLC and Jeffries Finance LLC acted as co-lead arrangers for the transaction.

Aveanna Healthcare (Nasdaq: AVAH) ha completato con successo una significativa rifinanziamento del debito. L'azienda ha rifinanziato i prestiti a tasso primo privilegio per 886,0 milioni di dollari e ha assicurato nuovi prestiti a tasso primo privilegio per 439,0 milioni di dollari, portando il totale a 1,325 miliardi di dollari con una scadenza estesa al 2032.

Inoltre, AVAH ha aumentato la sua linea di credito rotativa da 170,3 milioni a 250,0 milioni, estendendo la scadenza al 2030. L'azienda ha utilizzato i proventi per rimborsare integralmente i prestiti secondari ipotecari di 415,0 milioni di dollari. Barclays Bank PLC e Jeffries Finance LLC hanno agito come co-arranger principali della transazione.

Aveanna Healthcare (Nasdaq: AVAH) ha completado con éxito una importante refinanciación de deuda. La empresa ha refinanciado sus préstamos a primera hipoteca por 886,0 millones de dólares y ha asegurado 439,0 millones de dólares en nuevos préstamos a primera hipoteca, elevando el total a 1.325 millones de dólares con vencimiento extendido hasta 2032.

Además, AVAH incrementó su facilidad de crédito revolvente de 170,3 millones a 250,0 millones, extendiendo su vencimiento hasta 2030. La empresa utilizó los fondos para cancelar por completo sus préstamos de segunda hipoteca de 415,0 millones de dólares. Barclays Bank PLC y Jeffries Finance LLC actuaron como coarrangers principales de la operación.

Aveanna Healthcare (Nasdaq: AVAH)는 중요한 부채 재조정을 성공적으로 완료했습니다. 회사는 8억8600만 달러의 선순위 담보 대출추가 선순위 담보 대출 4,3900만 달러를 확보하여 총액을 13억2500만 달러로 늘리고 만기를 2032년으로 연장했습니다.

또한 AVAH는 가변금리 신용한도를 1억7030만 달러에서 2억5000만 달러로 늘렸고 만기도 2030년으로 연장했습니다. 회사는 4억1500만 달러의 2순위 담보 대출을 전액 상환하기 위해 자금을 사용했습니다. 거래의 공동 주관사로 Barclays Bank PLC와 Jeffries Finance LLC가 역할을 하였습니다.

Aveanna Healthcare (Nasdaq: AVAH) a effectué avec succès une refonte importante de sa dette. L'entreprise a refinancé ses emprunts senior garantis de premier rang pour 886,0 millions de dollars et a sécurisé 439,0 millions de dollars de nouveaux emprunts senior garantis de premier rang, portant le total à 1,325 milliard de dollars avec une échéance repoussée à 2032.

En outre, AVAH a augmenté sa facilité de crédit renouvelable de 170,3 millions à 250,0 millions, prolongeant son échéance jusqu'en 2030. L'entreprise a utilisé les fonds pour rembourser intégralement ses emprunts de second rang de 415,0 millions de dollars. Barclays Bank PLC et Jeffries Finance LLC ont agi en tant que co-arrangeurs principaux de la transaction.

Aveanna Healthcare (Nasdaq: AVAH) hat eine bedeutende Schuldenrefinanzierung erfolgreich abgeschlossen. Das Unternehmen hat seine 1er-Hypothekendarlehen in Höhe von 886,0 Millionen USD refinanziert und zusätzliche 1er-Hypothekendarlehen in Höhe von 439,0 Millionen USD gesichert, wodurch sich die Gesamtsumme auf 1,325 Milliarden USD erhöht und die Fälligkeit auf 2032 verlängert wurde.

Zusätzlich hat AVAH seine revolvierende Kreditfazilität von 170,3 Millionen USD auf 250,0 Millionen USD erhöht und die Fälligkeit auf 2030 verlängert. Das Unternehmen verwendete die Mittel, um seine 2. Rang-Hypothekendarlehen in Höhe von 415,0 Millionen USD vollständig zurückzuzahlen. Barclays Bank PLC und Jeffries Finance LLC fungierten als Co-Lead Arranger der Transaktion.

Aveanna Healthcare (Nasdaq: AVAH) أتمت بنجاح عملية إعادة تمويل ديون مهمة. قامت الشركة بإعادة تمويل قروض الرهن الأول بقيمة 886.0 مليون دولار ووفرت قروض رهن أول إضافية بقيمة 439.0 مليون دولار، ليصل الإجمالي إلى 1.325 مليار دولار مع تمديد تاريخ الاستحقاق حتى 2032.

بالإضافة إلى ذلك، زادت AVAH تسهيلات ائتمانها المتداولة من 170.3 مليون دولار إلى 250.0 مليون دولار، مع تمديد تاريخ الاستحقاق حتى 2030. استخدمت الشركة العوائد لسداد جميع قروض الرهن الثانوي بقيمة 415.0 مليون دولار. عملت Barclays Bank PLC و Jeffries Finance LLC كمنظّمين مشاركين للصفقة.

Aveanna Healthcare (Nasdaq: AVAH) 已成功完成一项重要的债务再融资交易。公司对其8.86亿美元的一级留置权定贷进行了再融资,并获得4.39亿美元的增量一级留置权定贷,总额达到13.25亿美元,期限延长至2032年。

此外,AVAH将其循环信贷额度从1.703亿美元提升至2.50亿美元,并将到期日延长至2030年。公司使用所得资金完全偿还了4.15亿美元的二级留置权定贷。Barclays Bank PLC和Jeffries Finance LLC担任本笔交易的共同主承销行。

Positive
  • None.
Negative
  • Increased total first lien term loan debt to $1.325 billion from $886.0 million
  • Added $439.0 million in incremental first lien term loans

Insights

Aveanna's comprehensive debt refinancing extends maturities, enhances liquidity, and strengthens its balance sheet position for future growth opportunities.

Aveanna Healthcare has executed a significant balance sheet restructuring that addresses both near-term obligations and long-term financial flexibility. The company has successfully refinanced $886 million in existing first lien term loans while securing an additional $439 million in incremental first lien borrowing. This strategic move allowed Aveanna to completely retire its $415 million second lien term loans, effectively consolidating its debt structure.

The maturity extension is particularly noteworthy - pushing first lien loan maturities to 2032 (a 7+ year extension) and revolving credit facilities to 2030. This substantially improves Aveanna's debt maturity profile, eliminating any near-term refinancing pressure. The expanded revolving credit facility, increased from $170.3 million to $250 million, provides 46.8% more liquidity cushion for operational needs and potential strategic opportunities.

What's most telling about this transaction is the willingness of capital markets to support Aveanna's refinancing at a scale of $1.325 billion in total. This signals strong lender confidence in the company's operational trajectory and business model. While the announcement doesn't disclose interest rates or specific terms, the consolidation under first lien debt typically suggests more favorable overall financing costs compared to maintaining second lien obligations. The involvement of Barclays and Jefferies as arrangers adds credibility to the transaction.

By eliminating the second lien debt entirely, Aveanna has likely simplified its capital structure and reduced its overall interest burden, though exact savings aren't quantified. This comprehensive refinancing strengthens Aveanna's financial foundation as it pursues growth in the home healthcare sector, where stable funding is crucial for both operational continuity and strategic expansion.

ATLANTA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH) today announced the closing of its refinanced first lien credit facility. The refinanced credit facility provides for the refinancing of the $886.0 million principal balance of existing first lien term loans, the additional borrowing of $439.0 million in incremental first lien term loans, and the upsize of its revolving credit facility from $170.3 million of maximum availability to $250.0 million of maximum availability. The combined $1.325 billion first lien term loans' maturity dates were extended to 2032, and the revolving credit facility’s maturity date was extended from 2028 to 2030.

Proceeds from the incremental first lien term loans were used to repay in full the existing second lien term loans in the amount of $415.0 million, and as a result, the second lien term loan facility was subsequently terminated.

Barclays Bank PLC and Jeffries Finance LLC served as co-lead arrangers.

“This refinancing marks another important milestone in the company's continued momentum,” said Matt Buckhalter, Chief Financial Officer. “By extending maturities and increasing our available liquidity, including our undrawn revolving facility, we have strengthened our balance sheet and enhanced our ability to execute on our strategy. This progress reflects the strong operating performance we've delivered and the confidence our financing partners have in our business."

“This successful refinancing reflects our operating performance and the proven value of our national home care platform,” said CEO, Jeff Shaner. “We are grateful to our capital partners for their unwavering support of our mission and their commitment to our continued growth and expansion.”

About Aveanna Healthcare

Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.



Investor Contact
Matt Buckhalter
Chief Financial Officer
ir@aveanna.com

FAQ

What is the size of Aveanna Healthcare's (AVAH) new refinanced credit facility?

Aveanna's refinanced credit facility includes $1.325 billion in first lien term loans and a $250.0 million revolving credit facility.

When do Aveanna Healthcare's (AVAH) new credit facilities mature?

The first lien term loans mature in 2032, while the revolving credit facility matures in 2030.

How much did Aveanna Healthcare (AVAH) increase its revolving credit facility?

Aveanna increased its revolving credit facility maximum availability from $170.3 million to $250.0 million, representing a $79.7 million increase.

What was the purpose of Aveanna Healthcare's (AVAH) incremental term loan borrowing?

The $439.0 million incremental first lien term loan was used to repay the existing $415.0 million second lien term loans in full.

Who were the arrangers for Aveanna Healthcare's (AVAH) debt refinancing?

Barclays Bank PLC and Jeffries Finance LLC served as co-lead arrangers for the refinancing transaction.
Aveanna Healthcare Holdings, Inc.

NASDAQ:AVAH

AVAH Rankings

AVAH Latest News

AVAH Latest SEC Filings

AVAH Stock Data

1.77B
68.68M
5.67%
88.84%
2.14%
Medical Care Facilities
Services-home Health Care Services
Link
United States
ATLANTA